Journal article
Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities
- Alternative title:
- Proceedings from a conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City, May 22–23, 2025
- Abstract:
-
The cancer problem is expanding, particularly in low‐ and middle‐income countries (LMICs). Preventive measures can reduce the incidence by 40–50%, and cure rates have increased during the past decades in a number of cancers. However, optimizing prevention programmes and increasing cure rates of cancer remain significant research challenges. The main focus of the conference was on P4 Cancer Medicine (Predictive, Preventive, Personalized and Participatory), a comprehensive strategy encompassing...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.4MB, Terms of use)
-
- Publisher copy:
- 10.1002/1878-0261.70179
Authors
- Publisher:
- Wiley
- Journal:
- Molecular Oncology More from this journal
- Publication date:
- 2025-12-15
- Acceptance date:
- 2025-11-26
- DOI:
- EISSN:
-
1878-0261
- ISSN:
-
1574-7891
- Language:
-
English
- Keywords:
- Pubs id:
-
2350471
- UUID:
-
uuid_52513d32-f329-4e8c-8c32-37c621290de0
- Local pid:
-
pubs:2350471
- Source identifiers:
-
3567755
- Deposit date:
-
2025-12-16
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record